About PFE Dividend Returns
Pfizer Inc. (PFE) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of PFE over the past year?
Pfizer Inc. (PFE) delivered a total return of 11.12% over the past year when dividends are reinvested. The price-only return was 4.62%, meaning dividends contributed an additional 6.51 percentage points to total returns.
Q2How much would $10,000 invested in PFE be worth today?
A $10,000 investment in Pfizer Inc. one year ago would be worth $11,112 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $10,462. Dividend reinvestment added $651 to the portfolio value.
Q3Does PFE pay dividends?
Yes, Pfizer Inc. (PFE) pays dividends. In the last year, PFE paid approximately $0.00 per share in dividends. Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.
Q4Did PFE beat the S&P 500?
No, Pfizer Inc. (PFE) underperformed the S&P 500 by 4.33 percentage points over the past year. PFE delivered a total return of 11.12%, compared to the S&P 500's 15.45%. This means a passive S&P 500 index fund outperformed PFE by 4.33pp during this period.
Q5What is PFE's worst drawdown?
Pfizer Inc. (PFE) experienced a maximum drawdown of -19.23% over the past year, declining from its peak on 2025-03-07 to its trough on 2025-04-10. The stock recovered to its prior peak by 2025-10-01. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is PFE's long-term total return over 10, 20, or 30 years?
Pfizer Inc. (PFE) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 51.9% (4.3% CAGR) — $10,000 would have grown to $15,191. Over 20 years: 110.5% total return (3.8% CAGR) — $10,000 → $21,049. Over 30 years: 442.4% total return (5.8% CAGR) — $10,000 → $54,236. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was PFE's best and worst year?
Pfizer Inc.'s best calendar year was 1997 with a total return of 82.1%. Its worst year was 2023 with a total return of -40.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 122.7 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).